Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Non-Muscle Invasive Papillary Urothelial Carcinoma Metastatic to the Mandible.
Frydenlund N, Zakharia Y, Garje R, Dahmoush L, O'Donnell MA. Frydenlund N, et al. Among authors: garje r. J Investig Med High Impact Case Rep. 2018 Oct 16;6:2324709618806332. doi: 10.1177/2324709618806332. eCollection 2018 Jan-Dec. J Investig Med High Impact Case Rep. 2018. PMID: 30349834 Free PMC article.
Systemic Therapy Update on 177Lutetium-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer: ASCO Guideline Rapid Recommendation Q and A.
Garje R, Hope TA, Rumble RB, Parikh RA; Systemic Therapy Update on 177Lutetium-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer Guideline Expert Panel. Garje R, et al. JCO Oncol Pract. 2023 Mar;19(3):132-135. doi: 10.1200/OP.22.00753. Epub 2023 Jan 24. JCO Oncol Pract. 2023. PMID: 36693228 No abstract available.
Immunotherapy Advances in Urothelial Carcinoma.
Jain RK, Snyders T, Nandagopal L, Garje R, Zakharia Y, Gupta S. Jain RK, et al. Among authors: garje r. Curr Treat Options Oncol. 2018 Dec 15;19(12):79. doi: 10.1007/s11864-018-0598-x. Curr Treat Options Oncol. 2018. PMID: 30554335 Review.
Correction to: Immunotherapy Advances in Urothelial Carcinoma.
Jain RK, Snyders T, Nandagopal L, Garje R, Zakharia Y, Gupta S. Jain RK, et al. Among authors: garje r. Curr Treat Options Oncol. 2019 May 23;20(7):53. doi: 10.1007/s11864-019-0660-3. Curr Treat Options Oncol. 2019. PMID: 31119396
PARP Inhibitors in Prostate and Urothelial Cancers.
Garje R, Vaddepally RK, Zakharia Y. Garje R, et al. Front Oncol. 2020 Feb 7;10:114. doi: 10.3389/fonc.2020.00114. eCollection 2020. Front Oncol. 2020. PMID: 32117762 Free PMC article. Review.
46 results